Axim Biotechnologies Inc (AXIM)

[Devolution]

I don't think anyone will ever get Americans back in masks over a virus ever again, especially when, "Two weeks to flatten the curve" turned into 2 years of unnecessary lockdowns, unfounded mask directives, and unconstitutional vaccine mandates.

Keep in mind, there still is a truckers convoy headed to Washington, D.C.

Besides, the Russian invasion into the Ukraine has more than created enough of a distraction to keep the general population from seeing what Durham has been doing lately.

Personally, I'm thinking that now that the planned-demic is no longer useful to those politically in control, that there is no longer a motivation to oppose the issuance of an EUA for Immunopass.

THAT, coupled with the FDA's recent corruption exposure which may force the FDA to now try to make their process look more legitimate, could make an EUA for Immunopass more of a possibility.

We may be on our way out of that portion of the rollercoaster ride that is unpleasant and painful, and headed to the part where the ride is faster, less jarring, and so much more enjoyable.

Regardless of the near-term future of Immunopass, I still feel that the DED line will bring AXIM to $2.50 to $3 by year end - not a bad ROI for anyone averaged in at 50 cents or below.

Godspeed, and welcome back.

Hope your trip East and back home was a satisfying and productive one.